Cargando…

Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study

BACKGROUND AND OBJECTIVES: New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackmore, Tania, Chepulis, Lynne, Rawiri, Keenan, Kidd, Jacquie, Stokes, Tim, Firth, Melissa, Elwood, Mark, Weller, David, Emery, Jon, Lawrenson, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295611/
https://www.ncbi.nlm.nih.gov/pubmed/34871389
http://dx.doi.org/10.1093/fampra/cmab155
_version_ 1784750085027921920
author Blackmore, Tania
Chepulis, Lynne
Rawiri, Keenan
Kidd, Jacquie
Stokes, Tim
Firth, Melissa
Elwood, Mark
Weller, David
Emery, Jon
Lawrenson, Ross
author_facet Blackmore, Tania
Chepulis, Lynne
Rawiri, Keenan
Kidd, Jacquie
Stokes, Tim
Firth, Melissa
Elwood, Mark
Weller, David
Emery, Jon
Lawrenson, Ross
author_sort Blackmore, Tania
collection PubMed
description BACKGROUND AND OBJECTIVES: New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of patients newly diagnosed with CRC. METHODS: Patients were recruited from the Midland region and interviewed about their diagnostic experience using a questionnaire based on a modified Model of Pathways to Treatment framework and SYMPTOM questionnaire. Descriptive statistics were used to describe the population characteristics. Chi-square analysis and logistic regression were used to analyse factors influencing diagnostic intervals. RESULTS: Data from 176 patients were analysed, of which 65 (36.9%) experienced a general practitioner (GP) diagnostic interval of >120 days and 96 (54.5%) experienced a total diagnostic interval (TDI) > 120 days. Patients reporting rectal bleeding were less likely to experience a long TDI (odds ratio [OR] 0.34, 95% confidence interval [CI]: 0.14–0.78) and appraisal/help-seeking interval (OR, 0.19, 95% CI: 0.06–0.59). Patients <60 were more likely to report a longer appraisal/help-seeking interval (OR, 3.32, 95% CI: 1.17–9.46). Female (OR, 2.19, 95% CI: 1.08–4.44) and Māori patients (OR, 3.18, 95% CI: 1.04–9.78) were more likely to experience a long GP diagnostic interval. CONCLUSION: NZ patients with CRC can experience long diagnostic intervals, attributed to patient and health system factors. Young patients, Māori, females, and patients experiencing change of bowel habit may be at particular risk. We need to increase symptom awareness of CRC for patients and GPs. Concentrated efforts are needed to ensure equity for Māori in access to screening, diagnostics, and treatment.
format Online
Article
Text
id pubmed-9295611
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92956112022-07-20 Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study Blackmore, Tania Chepulis, Lynne Rawiri, Keenan Kidd, Jacquie Stokes, Tim Firth, Melissa Elwood, Mark Weller, David Emery, Jon Lawrenson, Ross Fam Pract Health Service Research BACKGROUND AND OBJECTIVES: New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of patients newly diagnosed with CRC. METHODS: Patients were recruited from the Midland region and interviewed about their diagnostic experience using a questionnaire based on a modified Model of Pathways to Treatment framework and SYMPTOM questionnaire. Descriptive statistics were used to describe the population characteristics. Chi-square analysis and logistic regression were used to analyse factors influencing diagnostic intervals. RESULTS: Data from 176 patients were analysed, of which 65 (36.9%) experienced a general practitioner (GP) diagnostic interval of >120 days and 96 (54.5%) experienced a total diagnostic interval (TDI) > 120 days. Patients reporting rectal bleeding were less likely to experience a long TDI (odds ratio [OR] 0.34, 95% confidence interval [CI]: 0.14–0.78) and appraisal/help-seeking interval (OR, 0.19, 95% CI: 0.06–0.59). Patients <60 were more likely to report a longer appraisal/help-seeking interval (OR, 3.32, 95% CI: 1.17–9.46). Female (OR, 2.19, 95% CI: 1.08–4.44) and Māori patients (OR, 3.18, 95% CI: 1.04–9.78) were more likely to experience a long GP diagnostic interval. CONCLUSION: NZ patients with CRC can experience long diagnostic intervals, attributed to patient and health system factors. Young patients, Māori, females, and patients experiencing change of bowel habit may be at particular risk. We need to increase symptom awareness of CRC for patients and GPs. Concentrated efforts are needed to ensure equity for Māori in access to screening, diagnostics, and treatment. Oxford University Press 2021-12-06 /pmc/articles/PMC9295611/ /pubmed/34871389 http://dx.doi.org/10.1093/fampra/cmab155 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Health Service Research
Blackmore, Tania
Chepulis, Lynne
Rawiri, Keenan
Kidd, Jacquie
Stokes, Tim
Firth, Melissa
Elwood, Mark
Weller, David
Emery, Jon
Lawrenson, Ross
Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
title Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
title_full Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
title_fullStr Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
title_full_unstemmed Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
title_short Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
title_sort patient-reported diagnostic intervals to colorectal cancer diagnosis in the midland region of new zealand: a prospective cohort study
topic Health Service Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295611/
https://www.ncbi.nlm.nih.gov/pubmed/34871389
http://dx.doi.org/10.1093/fampra/cmab155
work_keys_str_mv AT blackmoretania patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT chepulislynne patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT rawirikeenan patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT kiddjacquie patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT stokestim patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT firthmelissa patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT elwoodmark patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT wellerdavid patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT emeryjon patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy
AT lawrensonross patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy